Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology, and dermato-oncology. Founded in 1976, Helsinn has nearly 50 years of experience in the pharmaceutical industry, with an extensive network of long-standing trusted partners enabling a commercial presence in about 150 countries. Helsinn Healthcare SA, headquartered in Lugano (Switzerland), oversees the activities of the three Helsinn Group’s subsidiaries (Helsinn Birex Pharmaceuticals Ltd., Helsinn Therapeutics (U.S.), Inc., Helsinn Pharmaceuticals (Beijing) Co., Ltd.), defining and implementing the Group’s strategy. Our mission is to champion and support patients with cancer and chronic diseases at every stage of their journey, by providing them with the best medications and solutions based on their needs and preferences. Follow our LinkedIn page to stay updated with news from Helsinn Group! If you are interested in joining us, please visit our website (www.helsinn.com): applications should only be submitted via the appropriate country portal, available under “Careers – Join us” website section. * This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional.
External link for Helsinn Group
Helsinn Group reposted this
The stage is set for #MASCC25! If you're attending the The Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, come visit us at booth 12. We're excited to share with you our dedication to supporting cancer patients’ treatment journey. #MASCC25 #SupportiveCare #SuppOnc
We're excited to keep the momentum going with the third episode of #HelsinnConversations! 🎬 Ready to dive into Helsinn? Join us as Enrico Florio, Alliance Manager, and Monica Pisani, Data & AI Management Officer, reveal their favourite projects and share more fascinating insights! 📺 Tune in now and be sure to leave your comments! #Helsinn #OurPeople
Last week, we had the pleasure of hosting a brand meeting at our Lugano headquarters, centred around Mycosis Fungoides-Cutaneous T-Cell Lymphoma (MF-CTCL). Under the inspiring theme "Together We Thrive", this event was a fantastic opportunity to exchange insights and advancements with our commercial partners, Recordati and Rafa Laboratories. Throughout the meeting, we shared best practices, discussed ongoing medical and marketing activities, and laid out future plans. By working together, we can leverage our collective expertise and resources to increase the awareness about MF-CTCL, anticipate the diagnosis, ultimately improving outcomes and patient’s quality of life. Our approach to partnerships is a key strength that drives us to constantly improve our solutions and better meet the patients’ needs. Together, we are making strides in the fight against rare diseases, ensuring that no patient is left behind. #Helsinn #GlobalBrandMeeting #TogetherWeThrive #Partnerships
Helsinn Group reposted this
Today we want to celebrate our longstanding relationship with the Cutaneous Lymphoma Foundation! Your unwavering dedication has a profound impact on the lives of patients and their families. We share a commitment to improve patient education and awareness about cutaneous lymphoma, provide comprehensive support to people affected by this rare disease and pursue research initiatives to improve treatments. Thank you for your incredible work and commitment. We look forward to making even greater strides in patient care and support. #Helsinn #CutaneousLymphomaFoundation #PatientSupport
Melissa Clayton, Alessandra Cogliati PharmD, Donna Roche, Silvia Olivari Tilola and Valeriia Zinoveva are attending the International Society for Cutaneous Lymphomas (ISCL) 2025 Annual Scientific & Business Meeting, taking place today in Lugano, Switzerland. This meeting is a fantastic opportunity for Helsinn to connect with leading experts in the field and discuss the latest advancements in cutaneous lymphomas! #ISCL2025 #CutaneousLymphoma #MycosisFungoides
Helsinn is proud to be among the sponsors of the International Society for Cutaneous Lymphomas (ISCL) 2025 Annual Scientific & Business Meeting, taking place in Lugano, Switzerland, on June 19. To mark the occasion, we are releasing this educational video about mycosis fungoides. The video aims to raise awareness of the importance of early diagnosis of this rare form of cutaneous lymphoma. #ISCL2025 #CutaneousLymphoma #MycosisFungoides #RaisingAwareness
📍 Live from BIO International 2025! Here we are - Luis Vieira, Lucia Stella Cafagna, Enrico Magnani and Paolo Ferrari - excited to talk to you about potential opportunities and collaborations. Don't miss out on discovering why Helsinn is the partner of choice! 🔗 More info on www.helsinn.com/business #Helsinn #BIO25
Welcome to Helsinn 🎉 We are excited to have Marco Colombo join our team and look forward to achieving outstanding results together! #Helsinn #Careers #WelcomeOnBoard
Helsinn Group reposted this
Recently, we had the privilege of joining an inspiring and impeccably organized global partner meeting hosted by Helsinn in Italy – a gathering dedicated to advancing antiemetic care for CINV (chemotherapy-induced nausea and vomiting) and improving patients’ quality of life. Under the powerful theme Aligning for Excellence, we explored three core pillars – patients, partnership, and excellence – together with partners from over 150 countries worldwide. Throughout the meeting, we shared best practices, uncovered the latest updates, and held thought-provoking discussions to boost global collaboration – all with a clear mission: helping patients stay on the chemo track and improve treatment outcomes. A heartfelt thank you to the Helsinn team for the warm Italian hospitality and flawless execution – a perfect balance of professionalism, generosity, and heart. 🙏 Looking forward to continuing this important journey together – united by science, driven by care, and committed to making a real difference for patients worldwide. Helsinn Group Israela YaminAmita NavonIrit Nezarel
🌍Today is #WorldEnvironmentDay, and in 2025 the focus is on plastic pollution - a major global challenge impacting our environment. At Helsinn, we’ve been taking action over the past 5 years through our Plasticless Initiative. We introduced reusable containers in our canteen and are progressively eliminating plastic bottles, in favour of more eco-friendly solutions. More recently, in our manufacturing plant in Birex, we’ve installed three innovative machines to replace traditional overwrappers, thus reducing drastically plastic use also in our manufacturing chain. 💡 From everyday choices to smart technology, every step matters. 📄 Learn more in our Sustainability Report: https://lnkd.in/d4VfQxpR Join us in celebrating this step towards a more sustainable future! Helsinn Birex Pharmaceuticals Ltd. Helsinn Therapeutics (U.S.), Inc. #Helsinn #BeatPlasticPollution #GreenerProduction #PlasticlessInitiative #QualityOfLife
